Chemosaturation therapy for cancers in the liver

The future of CLL treatment: Balancing efficacy, safety, and cost: Introduction from the Chair

Making sense of the expanding armoury of treatment options for the less fit patient

Choosing the right treatment for each patient: The emergence of personalised healthcare in non-small cell lung cancer

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Updates on advances and trials from ASCO; geriatric oncology overview

Addressing the challenges of an aging population

Adverse effects of treatment on elderly patients

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Advances in geriatric, medical oncology